Earth Science Tech (ETST) Change in Receivables (2011 - 2026)
Earth Science Tech (ETST) posted Change in Receivables of $49936.0 for Q1 2026, down 36.73% on a QoQ basis from $78929.0 in Q4 2025, and up 242.04% year-over-year from $14599.6 in Q1 2025.
Earth Science Tech (ETST) Change in Receivables (2011 - 2026) Analysis & Trends
Earth Science Tech's Change in Receivables history runs 7 years deep, the most recent figure standing at $49936.0 for Q1 2026.
- Quarterly Change in Receivables rose 242.04% year-over-year to $49936.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $226990.0 (up 313.42% YoY) and the FY2026 annual result came in at $226990.0, up 313.42% from the prior year.
- Change in Receivables was $49936.0 for Q1 2026 at Earth Science Tech, down from $78929.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $212580.0 in Q2 2025 and bottomed at -$114455.0 in Q3 2025.
- A 4-year average of $29319.4 and a median of $49951.0 in 2023 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2024 — Change in Receivables tumbled 179.5% — and 2025, when it jumped 298.71%.
- Earth Science Tech's Change in Receivables stood at $49966.0 in 2023, then tumbled by 179.5% to -$39721.0 in 2024, then soared by 298.71% to $78929.0 in 2025, then plunged by 36.73% to $49936.0 in 2026.
- Business Quant data shows ETST's Change in Receivables at $49936.0 in Q1 2026, $78929.0 in Q4 2025, and -$114455.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -78.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 106.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -621.82 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -38.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 126.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 81.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Earth Science Tech | 41.03 Mn | 38.90 Mn | 6.27 Mn | 49,936.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 49,936.00 |
| Mar 31, 2026 | 49,936.00 |
| Dec 31, 2025 | 78,929.00 |
| Dec 31, 2025 | 78,929.00 |
| Sep 30, 2025 | -114,455.00 |
| Sep 30, 2025 | -114,455.00 |
| Jun 30, 2025 | 212,580.00 |
| Jun 30, 2025 | 212,580.00 |
| Mar 31, 2025 | -35,157.00 |
| Mar 31, 2025 | -35,157.00 |
| Dec 31, 2024 | -39,721.00 |
| Dec 31, 2024 | -39,721.00 |
| Sep 30, 2024 | -113,745.00 |
| Sep 30, 2024 | -113,745.00 |
| Jun 30, 2024 | 82,264.00 |
| Jun 30, 2024 | 82,264.00 |
| Mar 31, 2024 | 122,597.00 |
| Mar 31, 2024 | 122,597.00 |
| Dec 31, 2023 | 49,966.00 |
| Dec 31, 2023 | 49,966.00 |